Literature DB >> 8923852

Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism.

S J Silverberg1, F G Locker, J P Bilezikian.   

Abstract

Most patients with primary hyperparathyroidism have reduced radial and preserved vertebral bone density. We have identified a subset of patients with low lumbar spine bone density at diagnosis. This study assessed the effect of parathyroidectomy (undertaken based upon accepted surgical guidelines) or nonintervention on bone mineral density (BMD) in these patients. Twenty-two of 143 (15%) patients with mild primary hyperparathyroidism had lumbar spine BMD more than 1.5 SD below the mean for an age- and sex-matched population (z-score). Fourteen underwent parathyroidectomy, whereas 8 were followed with no intervention. All had annual BMD measurements for 4 yr after enrollment or after surgery. After parathyroidectomy, there was a brisk sustained rise in lumbar spine BMD [yr 1, 15 +/- 3% (P < 0.005); yr 4, 21 +/- 4% (P < 0.01)]. In those followed without surgery, BMD did not change significantly at any site. Postmenopausal women showed the same pattern as the cohort as a whole, i.e. increased BMD after surgery [yr 1, 13 +/- 3% (P < 0.01); yr 4, 16 +/- 5% (P < 0.01)], but no worsening was found with nonintervention despite the passage of years in the menopause. We conclude that parathyroidectomy markedly improves lumbar spine BMD in patients with vertebral osteopenia. It is proposed that reduced cancellous bone density should become a new indication for surgery in primary hyperparathyroidism.

Entities:  

Mesh:

Year:  1996        PMID: 8923852     DOI: 10.1210/jcem.81.11.8923852

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

Review 1.  Parathyroidectomy for asymptomatic primary hyperparathyroidism (PHPT): is it worth the risk?

Authors:  D S Rao
Journal:  J Endocrinol Invest       Date:  2001-02       Impact factor: 4.256

Review 2.  Asymptomatic hyperparathyroidism: is the pendulum swinging back?

Authors:  K Siminoski
Journal:  CMAJ       Date:  2000-07-25       Impact factor: 8.262

Review 3.  Clinical spectrum of primary hyperparathyroidism.

Authors:  J P Bilezikian; S J Silverberg
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 4.  Primary hyperparathyroidism: pathophysiology and impact on bone.

Authors:  A Khan; J Bilezikian
Journal:  CMAJ       Date:  2000-07-25       Impact factor: 8.262

Review 5.  Bone strength in primary hyperparathyroidism.

Authors:  John P Bilezikian
Journal:  Osteoporos Int       Date:  2003-08-29       Impact factor: 4.507

Review 6.  Catabolic and anabolic actions of parathyroid hormone on the skeleton.

Authors:  B C Silva; A G Costa; N E Cusano; S Kousteni; J P Bilezikian
Journal:  J Endocrinol Invest       Date:  2011-09-23       Impact factor: 4.256

7.  A case of primary hyperparathyroidism with marked changes in bone mineral density and geometry after parathyroidectomy.

Authors:  Hiroshi Kaji; Mei-Fway Iu; Junko Naito; Toshitsugu Sugimoto; Kazuo Chihara
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

8.  Prevalence of primary hyperparathyroidism and impact on bone mineral density in elderly men: MrOs Sweden.

Authors:  Helene Siilin; Ewa Lundgren; Hans Mallmin; Dan Mellström; Claes Ohlsson; Magnus Karlsson; Eric Orwoll; Osten Ljunggren
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

9.  Recovery of bone mineral density in 126 patients after surgery for primary hyperparathyroidism.

Authors:  Erik Nordenström; Johan Westerdahl; Anders Bergenfelz
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

10.  Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women.

Authors:  Emily M Stein; Barbara C Silva; Stephanie Boutroy; Bin Zhou; Ji Wang; Julia Udesky; Chiyuan Zhang; Donald J McMahon; Megan Romano; Elzbieta Dworakowski; Aline G Costa; Natalie Cusano; Dinaz Irani; Serge Cremers; Elizabeth Shane; X Edward Guo; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2013-05       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.